Flex Pharma

Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders.

[Flex Pharma @flexpharma]

Flex Pharma Reports First Quarter 2018 Financial Results: https://t.co/ET9mceKbGF

[Flex Pharma @flexpharma]

Flex Pharma to Report Fourth Quarter and Full Year 2017 Results on March 7, 2018
https://t.co/ET9mceKbGF

[Flex Pharma @flexpharma]

Flex Pharma Presenting at BIO CEO on February 13, 2018
https://t.co/ET9mceKbGF

[Flex Pharma @flexpharma]

Enrollment Completed in Flex Pharma’s Phase 2 Exploratory Spasticity Study in MS - https://t.co/ET9mceKbGF

[Flex Pharma @flexpharma]

Flex Pharma Reports Third Quarter 2017 Financial Results - https://t.co/ET9mceKbGF

[Flex Pharma @flexpharma]

Flex Pharma Reports Positive Topline Data from Exploratory Phase 2 Trial of FLX-787 in ALS - https://t.co/ET9mceKbGF

[Flex Pharma @flexpharma]

Flex Pharma to Report Third Quarter 2017 Results on November 6, 2017 - https://t.co/ET9mceKbGF

[Flex Pharma @flexpharma]

Flex Pharma Names Dr. Roger Tung to Its Board of Directors - https://t.co/ET9mceKbGF

[Flex Pharma @flexpharma]

Flex Pharma Initiates CMT Phase 2 Trial with FLX-787 in US - https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

Flex Pharma Presenting at Upcoming Investor Conferences in September 2017 - https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

Flex Pharma Reports Second Quarter 2017 Financial Results - https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

Flex Pharma Initiates ALS Phase 2 Trial with FLX-787 in US - https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

Flex Pharma Names William McVicar President and Chief Executive Officer -https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

Flex Pharma to Report Second Quarter 2017 Results on August 2, 2017 - https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

FDA Grants Fast Track Designation to Flex Pharma's FLX-787 for #ALS - https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

HOTSHOT Partners With IRONMAN To Help Athletes Prevent Muscle Cramping https://t.co/GwpDtGuReY

[Flex Pharma @flexpharma]

Flex Pharma Announces Executive Leadership Transition -https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

Flex Pharma’s Phase 2 Trial with FLX-787 in Charcot-Marie-Tooth Endorsed by the Inherited Neuropathies Consortium - https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

Flex Pharma Presenting at Upcoming Investor Conferences in June 2017 - https://t.co/ooIOepvHpl

[Flex Pharma @flexpharma]

Flex Pharma Reports First Quarter 2017 Financial Results -https://t.co/ooIOepvHpl